HER2 Biomarkers News and reporting on HER2 biomarkers. Reveal Genomics, Dana-Farber Using HER2DX to Analyze Data in Three Breast Cancer Trials The partners aim to improve understanding of early-stage HER2-positive breast cancer patients and gain insights into optimal treatment strategies. Reveal Genomics Introduces HER2DX Breast Cancer Test in Europe, Plans US Expansion Premium The test is already available commercially in Spain, and the company intends to next launch its offering in Italy, as it expands to other European markets. Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications Premium The company failed in its first bid for breakthrough device designation but has now split out new specific indications for which it is building more persuasive utility data. HER2 Treatments See New Milestones in Colorectal Cancer, With Liquid Biopsy Identifying Responders Premium New data from a Japanese Phase II study have solidified a path forward for pertuzumab plus trastuzumab in HER2-positive colorectal cancer patients. Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium The OlympiA trial showed a disease-free survival benefit with adjuvant PARP inhibitor therapy for early-stage, BRCA1/2-mutated, HER2-negative breast cancer patients. May 7, 2021 Breast Cancer Immunotherapy Response Markers Emerge From Single-Cell Sequencing Study Feb 22, 2021 Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test Dec 14, 2020 Hummingbird Biosciences, Tempus Partner to ID Cancer Patients for Anti-HER3 Treatment Trial Oct 12, 2020 Spanish Startup Aims to Develop Novel Genomic Tests to Guide Breast Cancer Treatment Premium Aug 17, 2020 Thermo Fisher Scientific, Hengrui Therapeutics Ink CDx Deal for Pyrotinib in HER2-Mutated NSCLC Jun 12, 2020 New Data Support Role of Agendia BluePrint Test in Refining Breast Cancer Subtypes Premium Feb 13, 2020 Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel Oct 31, 2019 HER2 Amplification Confers Drug Sensitivity Across Tumor Types in New Study Premium Oct 18, 2019 Cervical Cancer Exomes Point to Potentially Targetable HER, PIK3CA Pathway Changes Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Jun 13, 2019 ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer Premium Apr 3, 2019 Project GENIE Used to Explore Impact of Rare Cancer Mutations on Treatment Response Premium Mar 4, 2019 Colon Cancer Patients Could Benefit From HER2 EGFR Non-Response Findings, Investigators Say Premium Dec 10, 2018 Metastatic ER+ Breast Cancers Acquire HER2 Mutations to Become Treatment Resistant Dec 5, 2018 Genentech Data Shows Breast Cancer Patient Subgroups May Benefit from Its Drugs Premium Sep 5, 2018 Study IDs Triple-Negative Breast Cancer Patients Who Respond to HER2-Targeted Therapy Premium Jul 17, 2018 Strata Oncology to Aid Puma Biotech in Recruiting for Neratinib HER2 Basket Study Feb 1, 2018 Publication Highlights Key Questions as Basket Studies Proliferate Premium Apr 12, 2017 After Korean Clinical Approval for Breast Cancer Prognostic, Gencurix Looks to Asian, US Markets Premium Apr 3, 2017 HER2 Mutant Basket Trial Confirms Drug Response Depends on Mutation, Cancer Type Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.